Cediranib

Cediranib

SCHEMBL4186434

[2H]C([2H])([2H])Oc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

FLT1FLT4KDRKITPDGFRAPDGFRB

The experimentally established mechanism targets of Cediranib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR known ✓ P35968 11/20 0.89
FLT4 known ✓ P35916 4/20 0.89
FLT1 known ✓ P17948 3/20 0.89
PDGFRB known ✓ P09619 2/20 0.89
KIT known ✓ P10721 1/20 0.89
PDGFRA known ✓ P16234 1/20 0.89
RET P07949 4/20 0.89
TEK Q02763 2/20 0.89
AURKB Q96GD4 2/20 0.89
PLK4 O00444 1/20 0.89
GAK O14976 1/20 0.89
EPHB6 O15197 1/20 0.89
RIPK2 O43353 1/20 0.89
ERN1 O75460 1/20 0.89
STK10 O94804 1/20 0.89
MAP4K4 O95819 1/20 0.89
CHEK2 O96017 1/20 0.89
ABL1 P00519 1/20 0.89
EGFR P00533 1/20 0.89
ERBB2 P04626 1/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cediranib SCHEMBL63147 0.94 KDR (1.00) KDRRETFLT4FLT1PDGFRB
Cediranib SCHEMBL29368143 0.94 KDR (1.00) KDRRETFLT4FLT1PDGFRB
Cediranib SCHEMBL29351458 0.94 KDR (1.00) KDRRETFLT4FLT1PDGFRB
Cediranib SCHEMBL29383181 0.94 KDR (1.00) KDRRETFLT4FLT1PDGFRB
SCHEMBL1685423 0.94 ABCB11 (1.00) KDRRETFLT4FLT1PDGFRB
SCHEMBL11953084 0.89 KDR (0.84) KDRRETFLT4FLT1PDGFRB
SCHEMBL20077514 0.89 KDR (0.89) KDRRETFLT4FLT1PDGFRB
SCHEMBL3198096 0.89 KDR (0.89) KDRRETFLT4FLT1PDGFRB
SCHEMBL13471998 0.89 KDR (0.89) KDRRETFLT4FLT1PDGFRB
SCHEMBL1401668 0.89 KDR (0.89) KDRRETFLT4FLT1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009094211-A1 QUINAZOLINE COMPOUNDS AND METHODS OF TREATING CANCER CONCERT PHARMACEUTICALS INC. (US) 2009-07-30 WO disclosed